|
Contents
|
|
|
|
Astrocytomas
|
|
|
|
E.
Lopez Aguilar, S. Delgado-Huerta, A. C. Sepulveda-Vildosola, V.
Wanzke-Del-angel, H. Rodriguez-Jimenez
Neoadjuvant
chemotherapy with temozolamide plus ifosfamide, carboplatin and etoposide
in pediatric patients with high grade astrocytomas. Phase II study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003.
|
|
|
Brain
Tumors
|
|
|
|
Fiorillo A, Maggi G,
Greco N, Migliorati R, D'Amico A, De Caro MD, Sabbatino MS, Buffardi F
Second-line chemotherapy with the association
of liposomal daunorubicin, carboplatin and etoposide in children with
recurrent malignant brain tumors
J Neurooncol. 2004 Jan;66(1-2):179-85.
|
|
Cheppail Ramachandran, Ziad Khatib,
Athena Pefkarou, John Fort, Hugo B. Fonseca, Steven J. Melnick and Enrique
Escalon
Tamoxifen modulation of etoposide cytotoxicity involves
inhibition of protein kinase C activity and insulin-like growth factor II
expression in brain tumor cells
J Neurooncol. 2004 Mar-Apr;67(1-2):19-28. (Abstract+)
|
|
|
Terasaki M, Bouffet E, Katsuki H, Fukushima S,
Shigemori M.
Pilot trial of the rate of response, safety, and tolerability of
temozolomide and oral VP-16 in patients with recurrent or treatment-induced
malignant central nervous system tumors
Surg Neurol.
2008 Jan;69(1):46-50
.JPG) Abstract
|
|
|
Embryonal
Tumors
|
|
|
|
|
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R,
Milano GM, Garrè ML, Donfrancesco A
A
multimodal strategy based on surgery, radiotherapy, ICE regimen and high
dose chemotherapy in atypical teratoid/rhabdoid tumours: a single
institution experience
J Neurooncol.
2009 Apr;92(2):177-83. Epub 2008 Nov 29
Abstract
|
|
Bevacizumab,
Celecoxib, Cyclophosphamide, Etoposide, Fenofibrate, Thalidomide
|
Peyrl
A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K,
Schmook MT, Haberler C, Leiss U, Slavc I.
Antiangiogenic metronomic therapy for children with recurrent embryonal
brain tumors.
Pediatr Blood Cancer. 2011 Dec 6;. [Epub ahead of print]
Abstract |
.gif) Related articles
|
|
H.
Shirato, J. Ikeda, H. Aoyama, N. Ishii, T. Taguchi, T. Kato, M. Tada, Y.
Sawamura
Low-dose
craniospinal irradiation and ifosfamide, cisplatine, and etoposide for embryonal
tumors in central nervous system
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
430
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.
|
|
|
Glioblastoma
|
|
|
|
C. F. Classen, M. Warmuth-Metz, K. Papke,
A. Trotter, J. E. A. Wolff, S. Wagner
Late
response to radiochemotherapy in pediatric glioblastoma: report on two
patients treated according to HIT-GBM protocols
Pediatr
Hematol Oncol. 2006
Dec;23(8):631-7. DOI: 10.1080/08880010600951088
|
|
J. M. Simon, G. Noel, K.
Hoang-Xuan, A. F. Carpentier, K. Mokhtari, S. Racadot, F. Baillet, J. J.
Mazeron
Radiotherapy and concomitant
weekly carboplatin and daily etoposide for patients with inoperable biopsy
proven glioblastoma multiforme
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1544
|
|
Recurrent
Tumors
|
|
|
|
Aoki
T, Mizutani T, Nojima K, Takagi T, Okumura R, Yuba Y, Ueba T, Takahashi JA,
Miyatake SI, Nozaki K, Taki W, Matsutani M
Phase
II study of ifosfamide, carboplatin, and etoposide in patients with a first
recurrence of glioblastoma multiforme
J Neurosurg.
2009 Jun 19. [Epub ahead of print]
Abstract
|
|
|
E. Schuller, R. Seidl, C. Wandl, K. Dieckmann, I. Slavc
Prolonged
Second Response To Cisplatin, Etoposide, And Ifosfamide In A Child With A Recurrent
Brainstem Glioblastoma
Pediatric
Hematology and Oncology, Volume 18, Number 4/June 1, 2001,
253 - 258
Abstract
|
|
|
Francesconi
AB, Dupre S, Matos M, Martin D, Hughes BG, Wyld DK, Lickliter JD
Carboplatin and etoposide combined with bevacizumab for the treatment of
recurrent glioblastoma multiforme
J Clin Neurosci. 2010 Jun 9;. [Epub ahead of print]
Abstract
|
|
|
Reardon
DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R,
Herndon JE 2nd, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman
HS
Phase II study of metronomic chemotherapy with bevacizumab for recurrent
glioblastoma after progression on bevacizumab therapy
J Neurooncol. 2010 Sep 19;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Glioma
|
|
|
|
Benyahia B, Huguet S, Decleves X, Mokhtari K, Criniere E, Bernaudin JF,
Scherrmann JM, Delattre JY
Multidrug resistance-associated protein MRP1 expression in
human gliomas: chemosensitization to vincristine and etoposide by indomethacin
in human glioma cell lines overexpressing MRP1
J Neurooncol. 2004 Jan;66(1-2):65-70.
|
|
Bourg
V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based
chemotherapy associated with valproate: increase of haematologic toxicity.
Ann Oncol 2001 Feb;12(2):217-9
Abstract | .png)
Reprint |
Related articles
|
|
|
Glioma
(High-Grade)
|
|
|
|
Recurrent
Tumors |
|
|
Lynn G. Feun, Angela Marini,
Howard Landy, Arnold Markoe, Deborah Heros, Carlos Robles,
Cristina Herrera and Niramol Savaraj
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent
malignant brain tumors
J Neurooncol. 2006 Oct 19; [Epub
ahead of print]
Abstract
|
|
|
Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill
A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J,
Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.
Phase
II study of metronomic chemotherapy for recurrent malignant gliomas in
adults.
Neuro Oncol. 2007 Jul;9(3):354-63.
Epub 2007 Apr 23.
Abstract |
Reprint |
Related articles
|
|
D.
Korones, M. Benita-Weiss, T. E. Coyle, P. Bushunow, L. Mechtler, H. S.
Friedman
A
phase II trial of temozolomide and oral VP-16 for adults with recurrent
malignant glioma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 447
|
|
Korones DN, Benita-Weiss M, Coyle TE, Mechtler L, Bushunow P,
Evans B, Reardon DA, Quinn JA, Friedman H
Phase
I study of temozolomide and escalating doses of oral etoposide for adults
with recurrent malignant glioma
Cancer 2003 Apr 15;97(8):1963-8
|
|
David
N Korones, Michal Benita-Weiss, Lazlo Mechtler, Peter Bushunow,
Brandon L Evans, Henry S Friedman
A
phase I study of temozolomide (Temodar) and escalating doses of oral VP-16
for adults with recurrent malignant glioma
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract
No. 2080
|
|
David
N Korones, Michal Benita-Weiss, Lazlo Mechtler, Peter Bushunow, Henry
S Friedman
A Phase 1 Study of Temozolomide (Temodar) and
Escalating Doses of Oral VP-16 for Adults with Recurrent Malignant Gliomas
ASCO Proceedings, 2001
Annual Meeting, Abstract No. 2055
|
|
|
Schäfer N, Tichy J, Thanendrarajan S, Kim Y, Stuplich M, Mack F, Rieger J,
Simon M, Scheffler B, Boström J, Steinbach JP, Herrlinger U, Glas M.
Ifosfamide,
Carboplatin and Etoposide in Recurrent Malignant Glioma.
Oncology. 2011 Jul
27;80(5-6):330-332. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Massimino
M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori
L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA,
Catania S, Sardi I, Giangaspero F
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood
progressive low-grade glioma
J
Neurooncol. 2010 Feb 12. [Epub ahead of print]
Abstract
| .png)
Full
Text |
Reprint
|
|
Mee Jeong Lee, Young Shin Ra,
Jun Bum Park, Hyun Woo Goo, Seung Do Ahn,
Shin Kwang Khang, Joon Sup Song, Yoon Jung Kim
and Thad T. Ghim
Effectiveness
of novel combination chemotherapy, consisting of 5-fluorouracil,
vincristine, cyclophosphamide and etoposide, in the treatment of low-grade
gliomas in children
Journal of
Neuro-Oncology, Volume 80, Number 3 / December, 2006, Pages 277-284,
Published online: 29 June 2006
|
|
|
Medulloblastoma
|
|
|
|
Celecoxib,
Cytarabine, Etoposide, Thalidomide
|
Nygaard
R, Kivivuori SM.
Treatment for recurrent
medulloblastoma with intrathecal liposomal cytarabine and systemic
metronomic combination therapy.
Anticancer Drugs. 2011 Dec 12;.
[Epub ahead of print]
Abstract |
Related articles
|
|
|
Saito R, Kumabe T, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga
T.
Combination
chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma:
single-institute experience and differences in efficacy for subgroups of
medulloblastoma.
Childs
Nerv Syst. 2011 May 18. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Silvani A, Gaviani P, Lamperti E, Botturi A, Dimeco F, Franzini A, Ferroli
P, Fariselli L, Milanesi I, Erbetta A, Pollo B, Salmaggi A.
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and
etoposide: a single institutional experience.
J Neurooncol.
2011 Aug 27. [Epub ahead of print]
Abstract |
Related articles
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 479
|
|
|
Metastatic
Tumors
|
|
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004. (Abstract+)
|
|
|
Oligo
T & Mixed Gliomas
|
|
|
|
L. Scopece, G. Cavallo, E.
Palmerini, E. Franceschi, A. Paioli, F. Spagnolli, S. Rimondini, R. Conforti, R.
Degli Esposti, L. Crino
Carboplatin and etoposide (CE)
chemotherapy in patients with recurrent or progressive oligodendroglial tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1562
|
|
|
Pediatric
Patients
|
|
|
|
Maura Massimino,
Lorenza Gandola, Roberto Luksch, Filippo Spreafico, Daria Riva, Carlo
Solero, Felice Giangaspero, Franco Locatelli, Marta Podda, Fabio
Bozzi, Emanuele Pignoli, Paola Collini, Graziella Cefalo, Marco Zecca,
Michela Casanova, Andrea Ferrari, Monica Terenziani, Cristina Meazza,
Daniela Polastri, Davide Scaramuzza, Fernando Ravagnani, and Franca
Fossati-Bellani
Sequential chemotherapy, high-dose
thiotepa, circulating progenitor cell rescue, and radiotherapy for
childhood high-grade glioma
Neuro-Oncology, Volume
7, Number 1, Pages 41 -- 48, January 2005. (Abstract+)
|
|
|
|
